An impact of PARP inhibition on drug sensitivity was observed in 6 of 8 of the M1/M2 AML samples, but the characteristic chromatin ring morphologies were observed in only one of eight samples (Table S3). This evidence concerns the gene PARP1 and acute myeloid leukemia.